Vijay K Lathi - Net Worth and Insider Trading
Vijay K Lathi Net Worth
The estimated net worth of Vijay K Lathi is at least $320,610 dollars as of 2024-12-27. Vijay K Lathi is the 10% Owner of Iterum Therapeutics PLC and owns about 97,087 shares of Iterum Therapeutics PLC (ITRM) stock worth over $194,174. Vijay K Lathi is also the Director of iRhythm Technologies Inc and owns about 1,405 shares of iRhythm Technologies Inc (IRTC) stock worth over $126,436. Details can be seen in Vijay K Lathi's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Vijay K Lathi has not made any transactions after 2018-05-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Vijay K Lathi
Vijay K Lathi Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Vijay K Lathi owns 10 companies in total, including Iterum Therapeutics PLC (ITRM) , iRhythm Technologies Inc (IRTC) , and MEI Pharma Inc (MEIP) among others .
Click here to see the complete history of Vijay K Lathi’s form 4 insider trades.
Insider Ownership Summary of Vijay K Lathi
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ITRM | Iterum Therapeutics PLC | 2018-05-30 | 10 percent owner |
| IRTC | iRhythm Technologies Inc | 2018-03-09 | director & 10 percent owner |
| MEIP | MEI Pharma Inc | 2012-12-18 | 10 percent owner |
 | | 2014-03-20 | 10 percent owner |
| | 2013-04-10 | 10 percent owner |
| | 2014-02-12 | 10 percent owner |
| | 2013-11-21 | director & 10 percent owner |
| | 2013-11-20 | other: Former 10% beneficial owner |
| | 2011-07-13 | 10 percent owner |
| | 2023-03-23 | 10 percent owner |
Vijay K Lathi Latest Holdings Summary
Vijay K Lathi currently owns a total of 2 stocks. Among these stocks, Vijay K Lathi owns 97,087 shares of Iterum Therapeutics PLC (ITRM) as of May 30, 2018, with a value of $194,174 and a weighting of 60.56%. Vijay K Lathi also owns 1,405 shares of iRhythm Technologies Inc (IRTC) as of March 9, 2018, with a value of $126,436 and a weighting of 39.44%.
Latest Holdings of Vijay K Lathi
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ITRM | Iterum Therapeutics PLC | 2018-05-30 | 97,087 | 2.00 | 194,174 |
| IRTC | iRhythm Technologies Inc | 2018-03-09 | 1,405 | 89.99 | 126,436 |
Holding Weightings of Vijay K Lathi
Vijay K Lathi Form 4 Trading Tracker
According to the SEC Form 4 filings, Vijay K Lathi has made a total of 0 transactions in Iterum Therapeutics PLC (ITRM) over the past 5 years. The most-recent trade in Iterum Therapeutics PLC is the acquisition of 44,178 shares on May 30, 2018, which cost Vijay K Lathi around $9 Million.
According to the SEC Form 4 filings, Vijay K Lathi has made a total of 0 transactions in iRhythm Technologies Inc (IRTC) over the past 5 years. The most-recent trade in iRhythm Technologies Inc is the sale of 114,018 shares on March 9, 2018, which brought Vijay K Lathi around $8 Million.
Insider Trading History of Vijay K Lathi
- 1
Vijay K Lathi Trading Performance
GuruFocus tracks the stock performance after each of Vijay K Lathi's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Vijay K Lathi is -0.24%. GuruFocus also compares Vijay K Lathi's trading performance to market benchmark return within the same time period. The performance of stocks bought by Vijay K Lathi within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Vijay K Lathi's insider trading performs compared to the benchmark.
Performance of Vijay K Lathi
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -1.13 | | | | | |
| Relative Return to S&P 500(%) | -2.66 | | | | | |
Vijay K Lathi Ownership Network
Vijay K Lathi Owned Company Details
What does Iterum Therapeutics PLC do?
Who are the key executives at Iterum Therapeutics PLC?
Vijay K Lathi is the 10 percent owner of Iterum Therapeutics PLC. Other key executives at Iterum Therapeutics PLC include Chief Scientific Officer Michael W. Dunne , director & President & CEO Fishman Corey N. , and Chief Medical Officer Sailaja Puttagunta .
Iterum Therapeutics PLC (ITRM) Insider Trades Summary
Over the past 18 months, Vijay K Lathi made no insider transaction in Iterum Therapeutics PLC (ITRM). Other recent insider transactions involving Iterum Therapeutics PLC (ITRM) include a net purchase of 55,000 shares made by Michael W. Dunne , and a net purchase of 10,000 shares made by Fishman Corey N. .
In summary, during the past 3 months, insiders sold 0 shares of Iterum Therapeutics PLC (ITRM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Iterum Therapeutics PLC (ITRM) were sold and 65,000 shares were bought by its insiders, resulting in a net purchase of 65,000 shares.
Iterum Therapeutics PLC (ITRM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Iterum Therapeutics PLC Insider Transactions
Vijay K Lathi Mailing Address
Above is the net worth, insider trading, and ownership report for Vijay K Lathi. You might contact Vijay K Lathi via mailing address: C/o New Leaf Venture Partners, 2500 Sand Hill Road, Suite 203, Menlo Park Ca 94025.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
